SREBP1 as a potential biomarker predicts levothyroxine efficacy of differentiated thyroid cancer
収録刊行物
-
- Biomedicine & Pharmacotherapy
-
Biomedicine & Pharmacotherapy 123 109791-, 2020-03
Elsevier BV